BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 30730284)

  • 1. The Aftermath of Surviving Acute Radiation Hematopoietic Syndrome and its Mitigation.
    Micewicz ED; Iwamoto KS; Ratikan JA; Nguyen C; Xie MW; Cheng G; Boxx GM; Deriu E; Damoiseaux RD; Whitelegge JP; Ruchala PP; Avetisyan R; Jung ME; Lawson G; Nemeth E; Ganz T; Sayre JW; McBride WH; Schaue D
    Radiat Res; 2019 Apr; 191(4):323-334. PubMed ID: 30730284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further Characterization of Multi-Organ DEARE and Protection by 16,16 Dimethyl Prostaglandin E2 in a Mouse Model of the Hematopoietic Acute Radiation Syndrome.
    Wu T; Pelus LM; Plett PA; Sampson CH; Chua HL; Fisher A; Feng H; Liu L; Li H; Ortiz M; Chittajallu S; Luo Q; Bhatwadekar AD; Meyer TB; Zhang X; Zhou D; Fischer KD; McKinzie DL; Miller SJ; Orschell CM
    Radiat Res; 2023 May; 199(5):468-489. PubMed ID: 37014943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat Models of Partial-body Irradiation with Bone Marrow-sparing (Leg-out PBI) Designed for FDA Approval of Countermeasures for Mitigation of Acute and Delayed Injuries by Radiation.
    Fish BL; MacVittie TJ; Gao F; Narayanan J; Gasperetti T; Scholler D; Sheinin Y; Himburg HA; Hart B; Medhora M
    Health Phys; 2021 Oct; 121(4):419-433. PubMed ID: 34546222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitigation of Hematopoietic Syndrome of Acute Radiation Syndrome by 1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) is Associated with Regulation of Systemic Inflammation in a Murine Model of Total-Body Irradiation.
    Kim YJ; Jeong J; Park K; Sohn KY; Yoon SY; Kim JW
    Radiat Res; 2021 Jul; 196(1):55-65. PubMed ID: 33914879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing Pediatric Mouse Models of the Hematopoietic Acute Radiation Syndrome and the Delayed Effects of Acute Radiation Exposure.
    Patterson AM; Sellamuthu R; Plett PA; Sampson CH; Chua HL; Fisher A; Vemula S; Feng H; Katz BP; Tudor G; Miller SJ; MacVittie TJ; Booth C; Orschell CM
    Radiat Res; 2021 Apr; 195(4):307-323. PubMed ID: 33577641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing polyphenolic acetates as radiation countermeasure agents: current status and future perspectives.
    Venkateswaran K; Shrivastava A; Prasad AK; Parmar VS; Dwarakanath BS
    Drug Discov Today; 2020 Apr; 25(4):781-786. PubMed ID: 32062010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed effects of radiation exposure in a C57L/J mouse model of partial body irradiation with ~2.5% bone marrow shielding.
    Beach T; Bakke J; McDonald JT; Riccio E; Javitz HS; Nishita D; Kapur S; Bunin DI; Chang PY
    Front Public Health; 2024; 12():1349552. PubMed ID: 38544733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting Glycogen Synthase Kinase-3 Mitigates the Hematopoietic Acute Radiation Syndrome in a Sex- and Strain-dependent Manner in Mice.
    Daniel AR; Lee CL; Oh P; Luo L; Ma Y; Kirsch DG
    Health Phys; 2020 Sep; 119(3):315-321. PubMed ID: 32175929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed Captopril Administration Mitigates Hematopoietic Injury in a Murine Model of Total Body Irradiation.
    McCart EA; Lee YH; Jha J; Mungunsukh O; Rittase WB; Summers TA; Muir J; Day RM
    Sci Rep; 2019 Feb; 9(1):2198. PubMed ID: 30778109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes.
    Gasperetti T; Miller T; Gao F; Narayanan J; Jacobs ER; Szabo A; Cox GN; Orschell CM; Fish BL; Medhora M
    Front Pharmacol; 2021; 12():634477. PubMed ID: 34079456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BIO 300: a promising radiation countermeasure under advanced development for acute radiation syndrome and the delayed effects of acute radiation exposure.
    Singh VK; Seed TM
    Expert Opin Investig Drugs; 2020 May; 29(5):429-441. PubMed ID: 32450051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patents.
    Singh VK; Romaine PL; Newman VL; Seed TM
    Expert Opin Ther Pat; 2016 Dec; 26(12):1399-1408. PubMed ID: 27610458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Hematopoietic Syndrome of the Acute Radiation Syndrome in Rhesus Macaques: A Systematic Review of the Lethal Dose Response Relationship.
    MacVittie TJ; Farese AM; Jackson W
    Health Phys; 2015 Nov; 109(5):342-66. PubMed ID: 26425897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notch-Expanded Murine Hematopoietic Stem and Progenitor Cells Mitigate Death from Lethal Radiation and Convey Immune Tolerance in Mismatched Recipients.
    Milano F; Merriam F; Nicoud I; Li J; Gooley TA; Heimfeld S; Imren S; Delaney C
    Stem Cells Transl Med; 2017 Feb; 6(2):566-575. PubMed ID: 28191773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Radiation Dose and Variation in Neupogen® Initiation Schedule on the Mitigation of Myelosuppression during the Concomitant GI-ARS and H-ARS in a Nonhuman Primate Model of High-dose Exposure with Marrow Sparing.
    MacVittie TJ; Bennett AW; Farese AM; Taylor-Howell C; Smith CP; Gibbs AM; Prado K; Jackson W
    Health Phys; 2015 Nov; 109(5):427-39. PubMed ID: 26425903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human ghrelin mitigates intestinal injury and mortality after whole body irradiation in rats.
    Wang Z; Yang WL; Jacob A; Aziz M; Wang P
    PLoS One; 2015; 10(2):e0118213. PubMed ID: 25671547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed Effects of Acute Radiation Exposure (Deare) in Juvenile and Old Rats: Mitigation by Lisinopril.
    Medhora M; Gao F; Gasperetti T; Narayanan J; Khan AH; Jacobs ER; Fish BL
    Health Phys; 2019 Apr; 116(4):529-545. PubMed ID: 30624354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PreImplantation factor (PIF) therapy provides comprehensive protection against radiation induced pathologies.
    Shainer R; Almogi-Hazan O; Berger A; Hinden L; Mueller M; Brodie C; Simillion C; Paidas M; Barnea ER; Or R
    Oncotarget; 2016 Sep; 7(37):58975-58994. PubMed ID: 27449294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel oral formulation of BIO 300 confers prophylactic radioprotection from acute radiation syndrome in mice.
    Singh VK; Fatanmi OO; Wise SY; Carpenter A; Nakamura-Peek S; Serebrenik AA; Kaytor MD
    Int J Radiat Biol; 2022; 98(5):958-967. PubMed ID: 34554032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitigation of total body irradiation-induced mortality and hematopoietic injury of mice by a thrombopoietin mimetic (JNJ-26366821).
    Kumar VP; Holmes-Hampton GP; Biswas S; Stone S; Sharma NK; Hritzo B; Guilfoyle M; Eichenbaum G; Guha C; Ghosh SP
    Sci Rep; 2022 Mar; 12(1):3485. PubMed ID: 35241733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.